Mirikizumab showed superior maintenance efficacy over most treatments for ulcerative colitis (UC), according to a network ...
For patients with compensated MASH-related cirrhosis and obesity, metabolic surgery associated with lower risk for adverse liver outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback